Valeant's armour turns to plastic
![Do not rule out the possibility that Valeant fights back.](/content/dam/images/g/k/j/5/c/u/image.related.afrIndexLead.320x210.gn92g8.png/1456959149454.jpg)
The pharma group may be humbled and vulnerable, but it is not dead.
The pharma group may be humbled and vulnerable, but it is not dead.
State premiers have labelled as "gross hypocrisy" the federal government's approval of a 5.6 per cent increase in private health insurance premiums compared to an offer of just 2.5 per cent increased funding for the states to fund public hospitals.
Healthcare professionals are famously resistant to the notion that they should be doing more to help the government slow the rate of increase in spending.
Private hospital giant Ramsay Health Care has pulled out of a joint venture play with Chinese company Jinxin in the city of Chengdu.
A smarter form of radiation treatment for prostate cancer will be given to an Australian patient for the first time on Wednesday this week
HealthKit, a digital platform for medical practitioners and patients, has closed a $1.6 million funding round, as it prepares to expand offs...
The Faulding brand is averaging revenue growth of about 25 per cent as it cashes in on Chinese demand for infant formula, vitamins and super...
New Zealand-based Volpara Health Technologies will meet fund managers this week ahead of a run at the ASX-boards.
Students who are all-rounders at school, good at both the sciences and the humanities, make better doctors.
While many companies fail overseas Sonic Healthcare has quietly built up a giant global pathology business. But the risk of health funding c...
Unlimited access to business news and market insights across any device
Already a subscriber? Log in